FDA clears Boston Scientific’s insertable cardiac monitor system

Boston Scientific’s to LUX-Dx Insertable Cardiac Monitor System detect arrhythmias related to conditions, including atrial fibrillation, cryptogenic stroke and syncope. Credit: Boston Scientific Corporation.